作为痛风性关节炎的辅助治疗方法的 меридиан-释疗法:系统性审查和元分析
Xia Zhou1, Shulei Peng2, Lang Hu3
1Department of Chinese Medicine, General Hospital of Southern Theater Command, Guangzhou, Guangdong, 510010, China.
Journal of orthopaedic surgery and research
|August 19, 2025
概括
与西方医学相结合的午线神经释放疗法 (MSRT) 在痛风性关节炎 (GA) 患者中显著减少尿酸,疼痛和炎症. 这种联合疗法 (MSRTW) 也显示出良好的安全性和较少的不良事件与单独的西方医学相比.
科学领域:
- 综合医学是一个整体医学.
- 类风湿病学 类风湿病学
- 基于证据的实践.
背景情况:
- 痛风性关节炎 (GA) 是一种慢性炎症性疾病,其特征是高尿血和尿酸结晶沉积.
- 传统西方医学 (WM) 的治疗旨在控制疼痛并降低尿酸水平,但可能存在局限性和副作用.
- 午线神经释放疗法 (MSRT) 是一种补充疗法,可以在管理炎症状况方面提供好处.
研究的目的:
- 评价与传统西方医学 (MSRTW) 结合的美第安 - 脊柱释放疗法的疗效和安全性,用于治疗痛风性关节炎 (GA).
- 提供科学证据支持MSRTW在治疗GA的临床应用.
- 为了比较MSRTW的结果与单独的西方医学 (WM) 治疗.
主要方法:
- 在中国和英语数据库中进行了系统的文献搜索,以确定相关的随机对照试验 (RCT).
- 对6项涉及376名参与者的RCT数据进行了元分析,将MSRTW与单独的WM进行了比较.
- 主要结局包括血清尿酸 (SUA) 水平的变化,而次要结局评估视觉模拟尺度 (VAS) 疼痛评分,红细胞沉积率 (ESR) 和C反应蛋白 (CRP). 还分析了安全性和不良事件.
主要成果:
- 与WM组相比,MSRTW组在SUA水平上显示出统计学上显著的减少 (MD = -99.94,P < 0.001).
- MSRTW显著改善了疼痛缓解 (VAS得分:MD = -1.50,P < 0.001) 和减少了炎症标志物 (ESR和CRP).
- 在MSRTW组表现出较低的不良事件发生率,这表明一个有利的安全概况. 通过敏感性分析证实了强度.
结论:
- 作为西方医学 (WM) 的辅助剂的 меридиан-释放疗法 (MSRT) 在治疗痛风性关节炎 (GA) 中显示出显著的临床益处.
- MSRTW有效地减少尿酸沉积,缓解炎症,并改善关节功能,具有良好的安全性.
- 建议进一步进行高质量的多中心试验,以确认长期疗效并阐明由于研究局限性的潜在机制.
相关概念视频
Rheumatic Heart Disease III: Medical Management
32
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
32
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
267
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
267
Nephrotic Syndrome II : Assessment and Medical Management
21
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
21


